BusinessAbeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIABy Nasdaq OMXApr 23, 2018, 12:15 PM UTC
BusinessCapricor Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Duchenne Muscular Dystrophy TherapyBy Nasdaq OMXFeb 5, 2018, 4:11 PM UTC
BusinessAbeona Receives FDA Regenerative Medicine Advanced Therapy Designation for EB-101 Gene Therapy in Epidermolysis BullosaBy Nasdaq OMXJan 29, 2018, 1:45 PM UTC
